An estimated 25 to 50 percent of preschoolers do not get enough healthy sleep. Now, researchers at Albert Einstein College of Medicine have been awarded a five-year, $2.9 million grant from the National Institutes of Health to promote healthy sleep among these children. The investigators will partner with Head Start, the early childhood program for disadvantaged preschool children and their families.
Jonathan M. Backer, M.D., an internationally acclaimed molecular pharmacologist and sought-after mentor to promising young scientists, will chair the department of molecular pharmacology at Albert Einstein College of Medicine, effective September 17, 2015. Dr. Backer is professor of molecular pharmacology and biochemistry. The department’s prior co-chairs were Susan B. Horwitz, Ph.D., and Charles S. Rubin, Ph.D.
Steven C. Almo, Ph.D., an internationally recognized leader in the field of proteomics, has been named chair of the department of biochemistry at Albert Einstein College of Medicine. Dr. Almo is professor of biochemistry and of physiology & biophysics and holds the Wollowick Family Foundation Chair. Dr. Almo will assume the chair left vacant by Vern Schramm, Ph.D., who has led the biochemistry department for the past 28 years.
New research on sickle cell disease (SCD) has found that using antibiotics to deplete the body’s microbiome may prevent acute sickle cell crisis and could offer the first effective strategy for warding off the disease’s long-term complications, such as organ failure. The study, conducted by scientists at Albert Einstein College of Medicine and Montefiore Health System, could also lead to better treatment for other inflammatory blood-vessel disorders including septic shock. The findings were published online today in Nature.
Researchers at Albert Einstein College of Medicine (http://www.einstein.yu.edu/) and Montefiore Health System (http://www.montefiore.org/) have received a $1.2 million grant from New York State to advance their promising technology for treating paralysis and other effects of spinal cord injuries (SCI). The grant is one of nine totaling $5.7 million announced by Governor Cuomo. The funding will be administered by New York State Spinal Cord Injury Research program and represents the first round of competitive awards since funding was re-instated for the program in 2013.
Using real-time, high-resolution imaging, scientists have identified how a “doorway” in the blood vessel wall allows cancer cells to spread from breast tumors to other parts of the body. The findings support emerging tests that better predict if breast cancer will spread, which could spare women from unnecessary treatments and lead to new anti-cancer therapies. The research from Albert Einstein Cancer Center and Montefiore Einstein Center for Cancer Care published today in Cancer Discovery.
An innovative three-month elective course has helped make some first-year medical students at Albert Einstein College of Medicine more confident about dealing with health disparities they’ll likely encounter as physicians, according to a follow-up study published online today in the journal Academic Medicine.
Periodic telephone counseling can be a highly effective, low-cost tool for lowering blood-sugar levels in minority, urban adults with uncontrolled diabetes. The findings are the result of a clinical trial led by researchers at Albert Einstein College of Medicine and their collaborators at the New York City Department of Health and Mental Hygiene (Health Department). The study published online today in the American Journal of Preventive Medicine.
Albert Einstein College of Medicine of Yeshiva University and the Icahn School of Medicine at Mount Sinai have received a $10.5 million, 5-year grant from the National Institutes of Health (NIH) to continue their Diabetes Research Center (DRC), which has been newly named the Einstein-Mount Sinai DRC. The regional collaborative combines Einstein’s basic and clinical research strengths with Mount Sinai’s beta cell and community outreach expertise.
A team including scientists from Albert Einstein College of Medicine and the U.S. Army Medical Research Institute of Infectious Diseases has identified the molecular “lock” that the deadly Ebola virus must pick to gain entry to cells. The findings, made in mice, suggest that drugs blocking entry to this lock could protect against Ebola infection.
A survey of more than 1,000 U.S. adults has found that misperceptions about miscarriage and its causes are widespread. Results of the survey, conducted by researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Health System, show that feelings of guilt and shame are common after a miscarriage and that most people erroneously believe that miscarriages are rare. The findings were published online today in the journal Obstetrics & Gynecology.
Darrell G. Kirch, M.D., president and chief executive officer of the Association of American Medical Colleges will deliver the keynote address at the 2015 commencement ceremony for Albert Einstein College of Medicine of Yeshiva University. Einstein’s 57th graduation will take place at Lincoln Center’s Avery Fisher Hall on Thursday, May 28 at 3 p.m.
Albert Einstein College of Medicine of Yeshiva University and Montefiore Health System have named Theodore A. Kastner, M.D., co-director of the Kennedy Center, whose mission is to improve the quality of life of people with intellectual and developmental disabilities and their families, and director of its primary clinical arm, the Children's Evaluation and Rehabilitation Center (CERC). Dr. Kastner assumed the new post on April 6.
An experimental therapy developed by researchers at Albert Einstein College of Medicine of Yeshiva University cut in half the time it takes to heal wounds compared to no treatment at all. Details of the therapy, which was successfully tested in mice, were published online in the Journal of Investigative Dermatology.
As graduating medical students around the country learn their professional fates, members of the class of 2015 at Albert Einstein College of Medicine of Yeshiva University celebrated another successful Match Day. An annual rite of passage, Match Day is an event that takes place at medical schools across the country during which fourth-year medical students learn where and in what specialty they will complete their residency—setting the course of their medical careers.
Scientists at Albert Einstein College of Medicine have developed a fluorescence microscopy technique that for the first time shows where and when proteins are produced. This allows researchers to directly observe individual mRNAs as they are translated into proteins in living cells. It should help reveal how irregularities in protein synthesis contribute to human disease processes, including Alzheimer’s disease and other memory-related disorders. The research publishes in the March 20 edition of Science.
Scientists at Albert Einstein College of Medicine have designed a new type of vaccine that could be the first-ever for preventing genital herpes—one of the most common sexually transmitted diseases, affecting 500 million people worldwide. Using a counterintuitive approach, researchers were able to prevent both infections caused by herpes simplex virus type 2, which causes genital herpes. Findings from the research, conducted in mice, were published today in the online journal eLife.
Researchers at Albert Einstein College of Medicine of Yeshiva University have found a possible clue to why older mothers face a higher risk for having babies born with conditions such as Down syndrome that are characterized by abnormal chromosome numbers.
Each year nearly 600,000 people—mostly children under age five and pregnant women in sub-Saharan Africa—die from malaria, caused by single-celled parasites that grow inside red blood cells. The most deadly malarial species—Plasmodium falciparum—has proven notoriously resistant to treatment efforts. But thanks to a novel approach developed by scientists at Albert Einstein College of Medicine of Yeshiva University and described in the January 20 online edition of ACS Chemical Biology, researchers can readily screen thousands of drugs to find those potentially able to kill P. falciparum.
A study of nearly a half-million Americans has found that following cancer prevention guidelines from the American Cancer Society may modestly reduce your overall risk of developing cancer and have a greater impact on reducing your overall risk of dying. Having a healthy body weight and staying active appeared to have the most positive impact.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right